Source: Annual Congress 2011 - Innovative diagnostic methods for lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
J. I. Kurth, K. Darwiche, D. Theegarten, J. I. Baumbach, R. Purkhart, L. Freitag (Essen, Saarbruecken, Bernau, Germany). A step towards easier diagnosis of lung cancer: Detection of volatile organic compounds in air releasing tumour samples with ion- and differential mobility spectrometry. Eur Respir J 2011; 38: Suppl. 55, 4507

Member's Comments

No comment yet.

Related content which might interest you: A new possibility of process monitoring in lung cancer: Volatile organic compounds detected with ion mobility spectrometry to follow the success of the therapeutic process Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011 Differential ion mobility spectrometry (DMS) for use in non invasive diagnostic from exhaled air Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Volatile organic compounds (VOC) in exhaled breath in patients with lung cancer, using the analytical technique thermal desorber- gase chromatography-spectrometer mases Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012 Comprehensive analysis of volatile organic compounds in human breath gas samples Source: Eur Respir J 2003; 22: Suppl. 45, 131s Year: 2003 Investigating the reproducibility of real time breath measurements using proton transfer reaction - time of flight - mass spectrometry for breath of volatile organic compounds in COPD Patients. Source: International Congress 2018 – Biomarkers in COPD and asthma Year: 2018 Detection of differences in volatile organic compounds (VOCs) by ion mobility spectrometry (IMS) of exhaled breath in patients with interstitial lung diseases (ILDs) compared to healthy controls (HC) Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease Year: 2011 Clusters of biomarkers in exhaled breath detected by differential ion mobility spectrometry (DMS) Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 Differential ion mobility spectrometry for detection of metabolites in exhaled breath in airway diseases Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009 Breath analysis by ion mobility spectrometry allows to discriminate COPD from lung cancer patients. Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies Year: 2018 In vitro discrimination between mesothelioma and lung cancer based on headspace volatile profiling Source: Virtual Congress 2021 – Novel insights into the diagnosis, mechanism and treatment of malignant pleural disease Year: 2021 New contributions in the determination of volatile organic compounds (VOC) in lung cancer (LC) Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011 Identification of microorganisms based on gas chromatography-mass spectrometric analysis of volatile organic compounds in headspace gases Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011 Determination of volatile organic compounds in exhaled breath of patients with chronic obstructive pulmonary disease by gas chromatography mass spectrometry Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Volatile organic compounds (VOCs) in exhaled air of patients with lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 208s Year: 2003 Refining the breath fingerprint of mesothelioma patients by in vitro identification of cancer cell line-specific volatile metabolites Source: International Congress 2017 – Pleural and mediastinal malignancies Year: 2017 Detection of pregnancy in horses by breath analysis using differential ion mobility spectrometry (DMS) Source: Annual Congress 2011 - Lung function today and tomorrow I Year: 2011 Diagnostic accuracy of SELDI-TOF-MS (surface enhanced laser desabsorbtion ionization time of flight mass spectrometry) method in early diagnosis of lung cancer Source: Annual Congress 2011 - Innovative diagnostic methods for lung cancer Year: 2011 Detection of infectious agents in the airways by ion mobility spectrometry in exhaled breath Source: Annual Congress 2010 - Mechanisms of respiratory infections Year: 2010 The application of mass spectrometry to the analysis and characterization of protein and peptide composition in exhaled breath condensate of pneumo-oncological diseased persons Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 Volatile organic compounds (VOC) in exhaled air sampled through the working channel of a bronchoscope in lung cancer patients Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010